{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T16:11:42Z","timestamp":1698509502412},"reference-count":16,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T00:00:00Z","timestamp":1315267200000},"content-version":"vor","delay-in-days":5880,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Photoderm Photoimm Photomed"],"published-print":{"date-parts":[[1995,8]]},"abstract":"<jats:p>Mequitazine is a phenothiazine derivative antihistamine. We experienced 2 cases of mequitazine\u2010induced photosensitivity reaction in patients who took mequitazine for their dermatologic problems. Case no. 1 showed features of photoallergy such as 1\u2010month incubation period, decreased MED to UVA, strong positive photopatch test result, cross reaction to chlorpromazine, and angry back phenomenon found in allergic contact dermatitis. In addition, an immediate erythematous macule was observed on the photopatch test site of mequitazine directly after UV exposure which was similar to the immediate erythema noted in chlorpromazine photoallergy. During the follow\u2010up period of two months, there was transiently decreased MED to UVB, which became normalized after 1 month treatment with cyclophosphamide. In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross\u2010reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3\u2010year follow\u2010up period after discontinuation of the mequitazine. Photopatch tests to 1% mequitazine with 5 J\/cm<jats:sup>2<\/jats:sup> of UVA in 30 normal subjects were all negative, which means that 1% concentration may be appropriate for the photopatch test. Mequitazine seemed to play a part similar to chlorpromazine, and absence of mequitazine\u2010induced photosensitivity may be due to a relatively low dosage of the drug. However, dermatologists should be cautious about a photosensitivity reaction induced by mequitazine or other phenothiazine\u2010derivative drugs.<\/jats:p>","DOI":"10.1111\/j.1600-0781.1995.tb00161.x","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T10:47:43Z","timestamp":1315306063000},"page":"170-173","source":"Crossref","is-referenced-by-count":6,"title":["Two cases of mequitazine\u2010induced photosensitivity reactions"],"prefix":"10.1111","volume":"11","author":[{"given":"T. H.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. I.","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,9,6]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"575","volume-title":"The pharmacological basis of therapeutics","author":"Garrison JC.","year":"1992"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1991.tb03645.x"},{"key":"e_1_2_1_4_2","first-page":"843","article-title":"Phototest and photopatch test","volume":"31","author":"Youn JI.","year":"1993","journal-title":"Korean J Dermatol"},{"key":"e_1_2_1_5_2","first-page":"17","volume-title":"Contact dermatitis","author":"Fisher AA.","year":"1986"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2340\/0001555557325329","article-title":"Phenothiazine phototoxicity: an experimental study on chlorpromazine and related tricyclic drugs","volume":"57","author":"Ljunggren B","year":"1977","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archderm.1975.01630230071013","article-title":"Chlorpromazine photoallergy: coexistence of immediate and delayed type","volume":"111","author":"Horio T.","year":"1975","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_8_2","first-page":"930","article-title":"Persisterende lys\u2010reaktion efter proklorperazinbehandling","volume":"150","author":"Rasmussen HB","year":"1988","journal-title":"Ugeskr Laeger"},{"key":"e_1_2_1_9_2","first-page":"225","article-title":"Persistent light reaction due to phenothiazines in atopic disease","volume":"109","author":"Amblard P","year":"1982","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_1_10_2","first-page":"52","article-title":"Promethazine photosensitive dermatitis","volume":"11","author":"Leong YO.","year":"1970","journal-title":"Singapore Med J"},{"key":"e_1_2_1_11_2","first-page":"53","article-title":"The effect of chlorpromazine in some properties of DNA in solution","volume":"7","author":"Kantesaria P","year":"1975","journal-title":"Physiol Chem Phys"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1974.tb10679.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(69)90167-9"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12284175"},{"key":"e_1_2_1_15_2","first-page":"160","volume-title":"Photosensitivity diseases","author":"Harber LC","year":"1989"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70034-Q"},{"key":"e_1_2_1_17_2","first-page":"95","article-title":"How to avoid phototoxic reactions in photopatch testing with chlorpromazine","volume":"2","author":"Schneider S.","year":"1985","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Photodermatology, Photoimmunology &amp; Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0781.1995.tb00161.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0781.1995.tb00161.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T02:11:29Z","timestamp":1698372689000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0781.1995.tb00161.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["10.1111\/j.1600-0781.1995.tb00161.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0781.1995.tb00161.x","archive":["Portico"],"relation":{},"ISSN":["0905-4383","1600-0781"],"issn-type":[{"value":"0905-4383","type":"print"},{"value":"1600-0781","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,8]]}}}